
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, Journal Year: 2022, Volume and Issue: 1867(7), P. 159154 - 159154
Published: March 29, 2022
Language: Английский
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, Journal Year: 2022, Volume and Issue: 1867(7), P. 159154 - 159154
Published: March 29, 2022
Language: Английский
Journal of the American Heart Association, Journal Year: 2022, Volume and Issue: 11(6)
Published: March 2, 2022
Background MAT9001 is an omega-3 free fatty acid (FFA) formulation containing mainly eicosapentaenoic (EPA) and docosapentaenoic (DPA). Compared with icosapent ethyl (EPA-ethyl esters [EE]), EPA+DPA-FFA previously showed enhanced triglyceride lowering higher plasma EPA when both were administered once daily a very-low fat diet. This trial compared pharmacodynamic responses levels following twice dosing, meals, of EPA-EE in hypertriglyceridemic subjects consuming Therapeutic Lifestyle Changes Methods Results open-label, randomized, 2-way crossover trial, 28-day treatment periods separated by ≥28-day washout, was conducted at 8 US centers included 100 fasting triglycerides 1.70 to 5.64 mmol/L (150-499 mg/dL) (median 2.31 [204 mg/dL]; 57% women, average age 60.3 years). The primary end point least squares geometric mean percent change from baseline triglycerides. In the 94 analyzable data for periods, reduced baseline: 20.9% 18.3%, respectively (P=not significant). high-sensitivity C-reactive protein 5.8%; increased 8.5% (P=0.034). EPA, DPA, total (EPA+docosahexaenoic acid+DPA) concentrations 848%, 177%, 205%, respectively, corresponding changes 692%, 140%, 165% (all P<0.001). docosahexaenoic 1.7%; decreased 3.3% (P=0.011). Lipoprotein cholesterol apolipoprotein did not differ between treatments. Conclusions raised significantly more than EPA-EE. also without increasing low-density lipoprotein cholesterol. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT04177680.
Language: Английский
Citations
10Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, Journal Year: 2022, Volume and Issue: 1867(9), P. 159195 - 159195
Published: June 16, 2022
Language: Английский
Citations
10American Journal of Clinical Nutrition, Journal Year: 2023, Volume and Issue: 117(6), P. 1240 - 1247
Published: March 21, 2023
Language: Английский
Citations
6Nutrients, Journal Year: 2023, Volume and Issue: 15(7), P. 1748 - 1748
Published: April 3, 2023
A great number of chemically diverse pancreatic lipase (PL) inhibitors have been identified to tackle obesity; however, very few them entered clinical studies. The ethanolic extract sesame meal is a potent PL inhibitor, and its activity hinges exclusively on two free fatty acids: linoleic acid oleic acid, which were proven reduce postprandial triglyceride excursion in rats. Herein, investigate the efficacy extract, crossover trial, 30 healthy volunteers randomized receive containing experimental food or placebo along with high-fat meal. Treatment significantly lowered incremental serum concentration reduced area under curve (iAUC) by 16.8% (p-value = 0.03) compared placebo. Significant decreases remnant-like lipoprotein particle cholesterol low-density particles also observed, whereas high-density was increased. These results suggest that treatment triglycerides improved lipidemic profile after high dietary fat intake individuals, indicating substantial potential natural products rich these compounds for management obesity related conditions.
Language: Английский
Citations
6Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, Journal Year: 2022, Volume and Issue: 1867(7), P. 159154 - 159154
Published: March 29, 2022
Language: Английский
Citations
9